PMC3917596_01
Trend in platelet counts during treatment. The y-axis depicts platelet counts in thousands/mm3 and the timeline is plotted on the x-axis. The star indicates the time of the intracranial bleed. The dark bar shows the duration of bortezomib treatment and arrows indicate timing of the injections; the lighter bar shows the duration of rituximab treatment with arrows indicating the timing of the treatments.
1752-1947-8-19-1.jpg
PMC3917596_01_1752-1947-8-19-1.jpg
F1
Again, because of suboptimal compliance, she only received 10 out of 16 planned doses (Figure 1). By this time, she had received a total of 14 subcutaneous injections of bortezomib (Figure 1). Her platelet count remained well above 100,000 cells/mm3 with the exception of three counts, one of which was below 40,000 cells/mm3, for 14 weeks of follow-up after the cessation of all therapy (Figure 1).